Article Details

First Patients Dosed with Illuccix® - Telix's Approved Prostate Cancer Imaging Agent | BioSpace

Retrieved on: 2022-04-14 15:18:15

Tags for this article:

Click the tags to see associated articles and topics

First Patients Dosed with Illuccix® - Telix's Approved Prostate Cancer Imaging Agent | BioSpace. View article details on hiswai:

Excerpt

INDIANAPOLIS, April 14, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces first commercial doses ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up